Skip to content

Topical Modification of Dental Pain and Movement

Use of Transient Receptor Potential (TRP) modulating topical cream in pain management following wisdom tooth extraction

Status
Recruiting
Phases
Phase 3
Study type
Interventional
Source
ANZCTR
Registry ID
ACTRN12619001167156
Acronym
TRP - transient receptor potential
Enrollment
60
Registered
2019-08-20
Start date
2021-10-01
Completion date
2022-06-30
Last updated
2022-03-28

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

None listed

Brief summary

Wisdom tooth extraction often causes significant local tissue injury in a highly innervated area. This results in significant pain and loss of function. Reduced ability to open the jaw often also accompanies pain and lasts for several days. Dental nerves can express TRPV1, TRPA1 and TRPM3 and are known in allergy work to cause pain when stimulated by inflammatory mediators. Two products, a spray and cream, have been developed that target these receptors via a topical approach. This study will assess pain and mobility after a reproducible "injury" following wisdom teeth surgery, compared to placebo.

Interventions

Topical application of 2.5g (half a teaspoon) of TRP modulating cream and 1mL of spray following wisdom tooth extraction to the jawline and external cheek at site of wisdom tooth extraction as required for up to five days. Active ingredients are as follows: a. Mentha Arvensis (Peppermint Oil)0.1% b. Chamonilla Recutia (Matricaria) Flower oil 0.05% c. Panax Ginseng Extract 5% d. Aloe Vera powder 0.5% e. Taurine 0.35% f. Glycyrrhiza blabra (Liquorice extract)1% g. Norhydroguiaretic acid 3% h. Ep

Topical application of 2.5g (half a teaspoon) of TRP modulating cream and 1mL of spray following wisdom tooth extraction to the jawline and external cheek at site of wisdom tooth extraction as required for up to five days. Active ingredients are as follows: a. Mentha Arvensis (Peppermint Oil)0.1% b. Chamonilla Recutia (Matricaria) Flower oil 0.05% c. Panax Ginseng Extract 5% d. Aloe Vera powder 0.5% e. Taurine 0.35% f. Glycyrrhiza blabra (Liquorice extract)1% g. Norhydroguiaretic acid 3% h. Epigallocatechin3gallate (EGCG) (Green Tea)0.05% These are compounded with 25% glycerol.

Sponsors

Professor Peter Smith
Lead SponsorIndividual

Study design

Allocation
Randomised controlled trial
Primary purpose
Treatment

Eligibility

Sex/Gender
All
Age
14 Years to No maximum
Healthy volunteers
No

Inclusion criteria

Patients undergoing bilateral wisdom tooth extraction, 14 years and over.

Exclusion criteria

Patients with an intolerance to the spray, allergic reaction to spray/placebo ingredients, intellectually disabled participants and persons that speak languages other than English.

Outcome results

None listed

Source: ANZCTR · Data processed: Feb 4, 2026